The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20080340
The Journal of Experimental Medicine, Vol. 205, No. 12, 2899-2913
The Rockefeller University Press, 0022-1007 $30.00
© Park et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 9473K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, H.
Right arrow Articles by Iritani, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, H.
Right arrow Articles by Iritani, B. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity

Heon Park1, Karen Staehling-Hampton2, Mark W. Appleby2, Mary E. Brunkow2, Tania Habib1, Yi Zhang2, Fred Ramsdell2, H. Denny Liggitt1, Brian Freie3, Mark Tsang1, George Carlson4, Sherree Friend5, Charles Frevert1, and Brian M. Iritani1,3

1 The Department of Comparative Medicine, University of Washington, Seattle, WA 98195
2 Celltech R & D, Inc., Bothell, WA 98021
3 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
4 The McLaughlin Research Institute, Great Falls, MT 59405
5 Amnis, Inc., Seattle, WA 98121

CORRESPONDENCE Brian M. Iritani: biritani{at}u.washington.edu

Hem1 (Hematopoietic protein 1) is a hematopoietic cell-specific member of the Hem family of cytoplasmic adaptor proteins. Orthologues of Hem1 in Dictyostelium discoideum, Drosophila melanogaster, and Caenorhabditis elegans are essential for cytoskeletal reorganization, embryonic cell migration, and morphogenesis. However, the in vivo functions of mammalian Hem1 are not known. Using a chemical mutagenesis strategy in mice to identify novel genes involved in immune cell functions, we positionally cloned a nonsense mutation in the Hem1 gene. Hem1 deficiency results in defective F-actin polymerization and actin capping in lymphocytes and neutrophils caused by loss of the Rac-controlled actin-regulatory WAVE protein complex. T cell development is disrupted in Hem1-deficient mice at the CD4CD8 (double negative) to CD4+CD8+ (double positive) cell stages, whereas T cell activation and adhesion are impaired. Hem1-deficient neutrophils fail to migrate in response to chemotactic agents and are deficient in their ability to phagocytose bacteria. Remarkably, some Rac-dependent functions, such as Th1 differentiation and nuclear factor {kappa}B (NF-{kappa}B)–dependent transcription of proinflammatory cytokines proceed normally in Hem1-deficient mice, whereas the production of Th17 cells are enhanced. These results demonstrate that Hem1 is essential for hematopoietic cell development, function, and homeostasis by controlling a distinct pathway leading to cytoskeletal reorganization, whereas NF-{kappa}B–dependent transcription proceeds independently of Hem1 and F-actin polymerization.


Abbreviations used: CBC, complete blood count; DN, double negative; DP, double positive; ENU, N-ethylnitrosourea; Erk, extracellular regulated mitogen-activated protein kinase; GTP, guanosine-5'-triphosphate; HSC, hematopoietic stem cell; siRNA, small inhibitory RNA; SP, side population; WBC, white blood cell.

M.W. Appleby and F. Ramsdell's present address is ZymoGenetics, Inc., Seattle, WA 98102.

K. Staehling-Hampton's present address is Stowers Institute for Medical Research, Kansas City, MO 64110.

Y. Zhang's present address is Amgen Inc, San Francisco, CA 94080.

© 2008 Park et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS